Laizer Kornwasser, EVP, Company Group Chairman at Valeant Pharmaceuticals International, Inc. (VRX), bought 2,000 shares at $70.61 ($141K) on 2013-03-11, disclosed to the SEC on 2013-03-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| TDOC | SELL | 2024-05-02 | $264K | — | Filing → |
| TDOC | SELL | 2024-03-05 | $533K | — | Filing → |
| TDOC | SELL | 2024-02-02 | $302K | — | Filing → |